Director at U S Physical Therapy (NYSE: USPH) receives stock grant

Rhea-AI Filing Summary

Motsenbocker Anne reported acquisition or exercise transactions in this Form 4 filing.

U S Physical Therapy director Anne Motsenbocker received a grant of 2,306 shares of common stock at $61.61 per share as equity compensation. This award increased her direct holdings to 9,812 shares of the company’s stock.

The 2,306 granted shares are restricted stock. According to the terms, restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026, and 577 shares on March 6, 2027, if she remains a director on those dates.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Motsenbocker Anne

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,306	$61.61	$142K

Holdings After Transaction: Common Stock — 9,812 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Restricted stock grant: 2,306 shares Grant price: $61.61 per share Holdings after grant: 9,812 shares +3 more

6 metrics

Restricted stock grant 2,306 shares Common stock awarded to director on May 19, 2026

Grant price $61.61 per share Reference price for 2,306-share restricted stock award

Holdings after grant 9,812 shares Total direct U S Physical Therapy shares held post-transaction

First vesting tranche 1,153 shares Restrictions lapse on August 20, 2026 if still a director

Second vesting tranche 576 shares Restrictions lapse on November 20, 2026 if still a director

Third vesting tranche 577 shares Restrictions lapse on March 6, 2027 if still a director

Key Terms

restricted stock, Company Amended and Restated 2003 Stock Incentive Plan, Form 4

3 terms

restricted stock financial

"Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Company Amended and Restated 2003 Stock Incentive Plan financial

"Granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan."

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Motsenbocker Anne

(Last) (First) (Middle)

1300 W SAM HOUSTON PKWY S

SUITE 300

(Street)

HOUSTON TEXAS 77042

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
U S PHYSICAL THERAPY INC /NV [ USPH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/19/2026		A		2,306	A	$61.61	9,812(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if she is a director of the Company on those dates.

	/s/ Kate Venturina, as attorney-in-fact	05/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did USPH director Anne Motsenbocker report on this Form 4?

Anne Motsenbocker reported receiving a grant of 2,306 shares of U S Physical Therapy common stock. The shares are issued as restricted stock under a company incentive plan and represent equity-based compensation rather than an open-market purchase or sale transaction.

How many USPH shares did Anne Motsenbocker receive and at what value?

She was granted 2,306 shares of U S Physical Therapy common stock at a reference value of $61.61 per share. This figure reflects the grant price used for the award, not a cash purchase in the open market by the director.

What are the vesting terms for Anne Motsenbocker’s 2,306 restricted USPH shares?

The restricted shares vest in three tranches: 1,153 shares on August 20, 2026, 576 shares on November 20, 2026, and 577 shares on March 6, 2027. Each vesting date requires that she remain a director of the company on that date.

How many U S Physical Therapy shares does Anne Motsenbocker own after this grant?

Following the restricted stock grant, Anne Motsenbocker directly holds 9,812 shares of U S Physical Therapy common stock. This total includes the newly awarded 2,306 restricted shares, which will vest over time if she continues serving as a director.

What plan governed the restricted stock grant to USPH director Anne Motsenbocker?

The 2,306-share restricted stock award was granted under the Company Amended and Restated 2003 Stock Incentive Plan. This plan allows U S Physical Therapy to issue equity-based compensation to directors, aligning their interests with shareholders through stock ownership.